Atlas Trials

Intravenous Infusion of Human Mesenchymal Stem Cells (HMM910 ) in Postmenopausal Women With Osteoporosis at High Risk of Fracture

Clinical trial NCT06949137 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06949137
Sponsor
HELP Therapeutics Co., Ltd.
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Osteoporosis in Post-menopausal WomenOsteoporosis
Start date
2025-06-20
Primary completion
2026-03-06
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.